| |
 |
|
|
|
|
|
Poster: 86
Visits: 61
Title: Activated Peripheral Blood Lymphocytes Of Hepatocellular Carcinoma Patients (Hcc) Are Associated With Increased Risk Of Early Dermatologic Adverse Effects During Sorafenib Treatment
Authors: Josep Corominas Argente Del Castillo ,
Centre:
|
|
You must be registered to reply or comment.
|
|
ACTIVATED PERIPHERAL BLOOD LYMPHOCYTES OF HEPATOCELLULAR CARCINOMA PATIENTS (HCC) ARE ASSOCIATED WITH INCREASED RISK OF EARLY DERMATOLOGIC ADVERSE EFFECTS DURING SORAFENIB TREATMENT
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre:
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 91
Visits: 64
Title: Dual Targeting Of Tumor Associated Macrophages And Immunosuppressive Granulocytic Myeloid-Derived Suppressor Cells Augments Pd-1 Blockade In Cholangiocarcinoma
Authors: Emilien Loeuillard , Emilien Loeuillard
Centre:
|
|
|
|
